(Q43108135)

14 November 2017

Adipocyte-derived factors potentiate nutrient-induced production of plasminogen activator inhibitor-1 by macrophages (English)

1 reference

14 November 2017

1 reference

1 reference

9

Philipp E Scherer

1 reference

14 November 2017

Preeti Kishore

1

1 reference

14 November 2017

Weijie Li

2

1 reference

14 November 2017

Julia Tonelli

3

1 reference

14 November 2017

Do-Eun Lee

4

1 reference

14 November 2017

Sudha Koppaka

5

1 reference

14 November 2017

Kehao Zhang

6

1 reference

14 November 2017

Ying Lin

7

1 reference

14 November 2017

Sylvia Kehlenbrink

8

1 reference

14 November 2017

Meredith Hawkins

10

1 reference

14 November 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

Science Translational Medicine

14 November 2017

1 reference

14 November 2017

2

1 reference

14 November 2017

20

1 reference

14 November 2017

20ra15

1 reference

Obesity and diabetes in the developing world--a growing challenge

14 November 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

The role of plasminogen activator inhibitor 1 in renal and cardiovascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

On the role of plasminogen activator inhibitor-1 in adipose tissue development and insulin resistance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

Circadian variation and triggers of onset of acute cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

Molecular mechanisms of fibrinolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

Intermittent high glucose stimulate MCP-l, IL-18, and PAI-1, but inhibit adiponectin expression and secretion in adipocytes dependent of ROS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

PAI-1 and the metabolic syndrome: links, causes, and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

Age-dependent spontaneous coronary arterial thrombosis in transgenic mice that express a stable form of human plasminogen activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

Bone marrow plasminogen activator inhibitor-1 influences the development of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

Obesity is associated with macrophage accumulation in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

Kruppel-like factor 4 is a mediator of proinflammatory signaling in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

The complement component C5a induces the expression of plasminogen activator inhibitor-1 in human macrophages via NF-kappaB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

Plasma lipoprotein lipase after subcutaneous heparin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

GPIHBP1 and lipolysis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

Identification and localization of a fatty acid response region in the human plasminogen activator inhibitor-1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

Adipocyte differentiation induces dynamic changes in NF-kappaB expression and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

Macrophage-secreted factors induce adipocyte inflammation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

Plasminogen activator inhibitor-1 modulates adipocyte differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

Standard isolation of primary adipose cells from mouse epididymal fat pads induces inflammatory mediators and down-regulates adipocyte genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

Glycemic control determines hepatic and peripheral glucose effectiveness in type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

Fructose improves the ability of hyperglycemia per se to regulate glucose production in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000292

10.1126/SCITRANSLMED.3000292

21 January 2018

Identifiers

DOI

1 reference

14 November 2017

1 reference